CDK4/6i can also induce antitumor immunity by overcoming two tumor immunoevasion mechanisms via (i) presenting tumor surface antigens with enhanced efficiency and (ii) inhibiting immunosuppressive Treg cell proliferation (62). The gene discussed is CDK4; the disease is neoplasm.